Featured Articles

1. Early Product Characterization De-Risks Biologics Development 6/12/2019

   The relationship between physicochemical profile and biological activity — and how this relationship affects clinical performance — is key to informed decisions, accelerated development, and risk reduction.

2. How Solid-State Science Solves Your Toughest API Challenges 6/3/2026

   Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.

3. Process Development And Intensification For UF/DF Of Viral Vectors 6/3/2026

   Optimizing TFF in viral vector workflows can reduce processing time while improving yield. Comparing TMP and permeate control strategies highlights key trade-offs to guide your purification decisions.

4. A Simple And Powerful Solution For Accelerating Dissolution 5/5/2026

   Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.

5. Lipids CDMO Services: Custom Excipients Tailored To Your Needs 4/27/2026

   Advance your lipid‑based programs with a CDMO partner equipped to deliver customized excipients, proven scale‑up expertise, and reliable support from early development through commercialization.

6. Life Cycle Assessment Of Extended Use Strategies For Single-Use Assemblies 4/17/2026

   Examine how extending the use of single‑use assemblies can significantly reduce emissions, resource consumption, and waste in bioprocessing, offering a data‑backed path toward sustainability.

7. From Fermentation To Vaccination 4/8/2026

   Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.

8. Microbial Integrity Of Sampling Systems After Multiple Actuations 4/6/2026

   Repeated sampling doesn’t have to mean increased contamination risk. See how microbial ingress testing demonstrates sterility integrity after up to 50 sampling actuations.

9. Evaluation Of TFF Operating Control Strategies And Scalability 4/2/2026

   Gain insight into a comparison of TMP and permeate control strategies for viral vector TFF, highlighting impacts on flux, processing time, impurity removal, and scale-up predictability across development.

10. Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies 3/4/2026

    Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.